AR006315A1 - Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para preparar - Google Patents
Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para prepararInfo
- Publication number
- AR006315A1 AR006315A1 ARP970101091A ARP970101091A AR006315A1 AR 006315 A1 AR006315 A1 AR 006315A1 AR P970101091 A ARP970101091 A AR P970101091A AR P970101091 A ARP970101091 A AR P970101091A AR 006315 A1 AR006315 A1 AR 006315A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- derivatives
- procedure
- obtaining
- exclusive use
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000011647 vitamin D3 Substances 0.000 title 1
- 229940021056 vitamin d3 Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 210000001732 sebaceous gland Anatomy 0.000 abstract 1
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Liquid Crystal Substances (AREA)
- Furan Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Se refiere a derivados de 1,25 dihidroxi-16,22,23-trisdehidrocolecalciferol según fórmula (I), en donde R es hidroxi y R1 es H2 o CH2, o R es hidrógeno ofluor y R1 es CH2. Los compuestos de fórmula (I) son de utilidad como agentes para eltratamien to de enfermedades hiperproliferativas de la piel, tales comola psoriasis, enfermedades neoplásticas, tales como la leucemia, y enfermedades de las glándulas sebáceas tales como el acné y la dermatitis seborreica.También comprende elprocedimiento de obtención de los mismos, compuestos intermediarios para su exclusivo uso en dicho procedimiento, composiciónfarmacéutica que los contiene y empleo de dichos derivados para preparar composiciones farmacéuticas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1380996P | 1996-03-21 | 1996-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006315A1 true AR006315A1 (es) | 1999-08-25 |
Family
ID=21761865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101091A AR006315A1 (es) | 1996-03-21 | 1997-03-19 | Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para preparar |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0796843B1 (es) |
| JP (1) | JP2801587B2 (es) |
| KR (1) | KR100240541B1 (es) |
| CN (1) | CN1110477C (es) |
| AR (1) | AR006315A1 (es) |
| AT (1) | ATE240941T1 (es) |
| AU (1) | AU708679B2 (es) |
| BR (1) | BR9701404A (es) |
| CA (1) | CA2199893C (es) |
| CO (1) | CO4820396A1 (es) |
| CZ (1) | CZ85897A3 (es) |
| DE (1) | DE69722064T2 (es) |
| DK (1) | DK0796843T3 (es) |
| ES (1) | ES2198512T3 (es) |
| HR (1) | HRP970162A2 (es) |
| HU (1) | HUP9700609A3 (es) |
| ID (1) | ID16285A (es) |
| IL (1) | IL120469A0 (es) |
| MA (1) | MA26423A1 (es) |
| MX (1) | MX9702139A (es) |
| NO (1) | NO971217L (es) |
| NZ (1) | NZ314424A (es) |
| PE (1) | PE42998A1 (es) |
| PL (1) | PL319070A1 (es) |
| PT (1) | PT796843E (es) |
| SG (1) | SG70589A1 (es) |
| TR (1) | TR199700219A3 (es) |
| TW (1) | TW444001B (es) |
| YU (1) | YU10397A (es) |
| ZA (1) | ZA972302B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9625271D0 (en) * | 1996-12-04 | 1997-01-22 | Leo Pharm Prod Ltd | Chemical compounds |
| US6331642B1 (en) | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| KR101285720B1 (ko) * | 2012-03-02 | 2013-07-19 | 주식회사 유니크메디케어 | 여드름 개선용 조성물 |
| KR102493627B1 (ko) | 2015-11-26 | 2023-01-31 | 코웨이 주식회사 | 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA8923B (en) * | 1988-01-20 | 1989-09-27 | Hoffmann La Roche | 16-dehydro-vitamin d3-derivatives |
| DE69005897D1 (de) * | 1989-05-18 | 1994-02-24 | Hoffmann La Roche | Dehydrocholecalciferolderivate. |
-
1997
- 1997-03-06 AU AU15135/97A patent/AU708679B2/en not_active Ceased
- 1997-03-11 SG SG1997000771A patent/SG70589A1/en unknown
- 1997-03-12 PE PE1997000190A patent/PE42998A1/es not_active Application Discontinuation
- 1997-03-13 TW TW086103109A patent/TW444001B/zh active
- 1997-03-13 CA CA002199893A patent/CA2199893C/en not_active Expired - Fee Related
- 1997-03-14 EP EP97104387A patent/EP0796843B1/en not_active Expired - Lifetime
- 1997-03-14 DE DE69722064T patent/DE69722064T2/de not_active Expired - Fee Related
- 1997-03-14 PT PT97104387T patent/PT796843E/pt unknown
- 1997-03-14 AT AT97104387T patent/ATE240941T1/de not_active IP Right Cessation
- 1997-03-14 ES ES97104387T patent/ES2198512T3/es not_active Expired - Lifetime
- 1997-03-14 DK DK97104387T patent/DK0796843T3/da active
- 1997-03-17 NZ NZ314424A patent/NZ314424A/en unknown
- 1997-03-17 ZA ZA9702302A patent/ZA972302B/xx unknown
- 1997-03-17 NO NO971217A patent/NO971217L/no not_active Application Discontinuation
- 1997-03-17 IL IL12046997A patent/IL120469A0/xx unknown
- 1997-03-18 JP JP9064030A patent/JP2801587B2/ja not_active Expired - Fee Related
- 1997-03-19 ID IDP970894A patent/ID16285A/id unknown
- 1997-03-19 HU HU9700609A patent/HUP9700609A3/hu unknown
- 1997-03-19 YU YU10397A patent/YU10397A/sh unknown
- 1997-03-19 HR HR60/013,809A patent/HRP970162A2/xx not_active Application Discontinuation
- 1997-03-19 AR ARP970101091A patent/AR006315A1/es not_active Application Discontinuation
- 1997-03-20 BR BR9701404A patent/BR9701404A/pt not_active IP Right Cessation
- 1997-03-20 PL PL97319070A patent/PL319070A1/xx unknown
- 1997-03-20 CN CN97103358A patent/CN1110477C/zh not_active Expired - Fee Related
- 1997-03-20 MX MX9702139A patent/MX9702139A/es not_active IP Right Cessation
- 1997-03-20 CZ CZ97858A patent/CZ85897A3/cs unknown
- 1997-03-20 KR KR1019970009478A patent/KR100240541B1/ko not_active IP Right Cessation
- 1997-03-20 TR TR97/00219A patent/TR199700219A3/tr unknown
- 1997-03-20 CO CO97015089A patent/CO4820396A1/es unknown
- 1997-03-21 MA MA24528A patent/MA26423A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9713412A (pt) | Composição cosmética adequada para aplicação tópica à pele ou cabelo e processo de tratamento cosmético | |
| DK0654467T3 (da) | Vitamin D3-analoger | |
| AR002267A1 (es) | Compuestos de imidazol utiles para el tratamiento de patologias mediadas por citoquinas; composicion farmaceutica que los contiene; proceso para preparar dichos compuestos; uso del mismo para preparar dichas composiciones; compuestos intermediarios y procesos para su preparacion. | |
| BR9712073A (pt) | Processo para produção de compostos de ecteinascidina | |
| ATE253586T1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivat | |
| AR003955A1 (es) | Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen. | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| FI951614A (fi) | D-vitamiinisarjan 25-karboksyylihappojohdannaisia, menetelmät niiden valmistamiseksi, näissä menetelmissä käytettävät välituotteet, näitä johdansia sisältävät farmaseuttiset valmisteet ja näiden johdannaisten käyttö lääkeaineiden valmistukseen | |
| DE69001437D1 (de) | Neue vitamin d analoge. | |
| DK0580968T3 (da) | Fluorerede analoger af vitamin D3 | |
| AR017339A1 (es) | Derivados de d-homo-9, 10-secocolesta-23-in-3, 25-diol, su empleo, procedimiento para obtenerlos, composiciones farmaceuticas que los contienen, ycompuestos utiles como intermedios | |
| AR006058A1 (es) | Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido | |
| PE20000267A1 (es) | Derivados de ciclohexanodiol | |
| AR006315A1 (es) | Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para preparar | |
| ES2140765T3 (es) | Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene. | |
| PE26691A1 (es) | Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas | |
| UY23678A1 (es) | Procedimiento para la preparacion de analogos de la vitamina d3 | |
| MX9803966A (es) | 25-hidroxi-16-en-26,27-bishomo-colecalciferoles. | |
| ES2145480T3 (es) | Amidas de acido carbamoilcarboxilico. | |
| ES2143973T3 (es) | Procedimiento para la preparacion de acidos 7-(3-amino- asi como 3-aminometil-1-pirrolidinil)-3-quinoloncarboxilicos asi como -naftiridoncarboxilicos. | |
| ES2175371T3 (es) | Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres. | |
| ES526922A0 (es) | Un procedimiento para producir derivados de antraciclina | |
| ECSP972061A (es) | Derivados de 1,25 -dihidroxi-16, 22, 23-trien - colecalciferol | |
| ATE229937T1 (de) | Vitamin d 3? derivate und verfahren zur herstellung derselben | |
| MX9303392A (es) | Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |